Patents by Inventor Jagadeesh YERRI

Jagadeesh YERRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,6-disubstituted-2-pyridinaldoxime scaffolds
    Patent number: 12209090
    Abstract: The present invention relates to a compound of formula (I), or one of its pharmaceutically acceptable salts: (I) wherein R1, R2 and —X—Y— have specific definitions. It also relates to the use of such a compound in therapy; and to a process for preparing it.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: January 28, 2025
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE STRASBOURG, ETAT FRANCAIS (MINISTÈRE DES ARMÉES), REPRESENTE PAR LA DIRECTION CENTRALE DU SERVICE DE SANTÉ DES ARMEES
    Inventors: Rachid Baati, Richard Brown, José Dias, Alex Maryan-Instone, Jagadeesh Yerri
  • HYDROXY-PYRIDINALDOXIME SCAFFOLDS
    Publication number: 20240025854
    Abstract: The present invention relates to a compound of formula (I). It also relates to a pharmaceutical composition comprising at least one compound of formula (I) and at least one pharmaceutically acceptable support. Finally, it relates to the use of such a compound as a medicine, preferably in the treatment of a nervous and/or respiratory failure due to intoxication with at least one organophosphorous nerve agent; in the treatment of neurological diseases such as Alzheimer's disease; and/or in the treatment of cancer.
    Type: Application
    Filed: September 9, 2021
    Publication date: January 25, 2024
    Inventors: Rachid BAATI, Richard BROWN, José DIAS, Alex MARYAN-INSTONE, Florian NACHON, Jagadeesh YERRI, Camille VOROS
  • 6-Substituted 3-Fluoro-2-Pyridinaldoxime, 3-Fluoro-2-pyridine hydroxamic acid, and 3-Fluoro-2-Pyridinamidoxime scaffolds
    Patent number: 11370772
    Abstract: Disclosed is a compound of formula (II), as well as to a process for preparing the compounds of formula (II) by a chemoselective Sonogashira reaction. It also relates to a pharmaceutical composition including at least one compound of formula (II) and at least one pharmaceutically acceptable support. Finally, it relates to the use of such a compound as a medicine, preferably in the treatment of a nervous and/or respiratory failure due to intoxication with at least one organophosphorous nerve agent; in the treatment of neurological diseases such as Alzheimer's disease; and/or in the treatment of cancer; and/or for use as antiviral drug.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: June 28, 2022
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ DE STRASBOURG
    Inventors: Rachid Baati, Jagadeesh Yerri, José Dias
  • 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS
    Publication number: 20220081442
    Abstract: The present invention relates to a compound of formula (I), or one of its pharmaceutically acceptable salts: (I) wherein R1, R2 and —X—Y— have specific definitions. It also relates to the use of such a compound in therapy; and to a process for preparing it.
    Type: Application
    Filed: February 14, 2020
    Publication date: March 17, 2022
    Inventors: Rachid BAATI, Richard BROWN, José DIAS, Alex MARYAN-INSTONE, Jagadeesh YERRI
  • 6-SUBSTITUTED 3-FLUORO-2-PYRIDINALDOXIME, 3-FLUORO-2-PYRIDINE HYDROXAMIC ACID, AND 3-FLUORO-2-PYRIDINAMIDOXIME SCAFFOLDS
    Publication number: 20200255399
    Abstract: Disclosed is a compound of formula (II), as well as to a process for preparing the compounds of formula (II) by a chemoselective Sonogashira reaction. It also relates to a pharmaceutical composition including at least one compound of formula (II) and at least one pharmaceutically acceptable support. Finally, it relates to the use of such a compound as a medicine, preferably in the treatment of a nervous and/or respiratory failure due to intoxication with at least one organophosphorous nerve agent; in the treatment of neurological diseases such as Alzheimer's disease; and/or in the treatment of cancer; and/or for use as antiviral drug.
    Type: Application
    Filed: October 17, 2018
    Publication date: August 13, 2020
    Inventors: Rachid BAATI, Jagadeesh YERRI, José DIAS